纽瑞克斯制药 NRIX
$15.30 +$0.46 (+3.10%)
休市 · Nov 7, 5:10 am ET · 最新盘后价 $15.07 -1.50%
开盘$15.10
昨收$14.84
当日区间$14.79 – $15.52
成交量2.98M
市值$1.67B
市盈率（TTM）6.3
股息率–
NRIX 相关新闻
匹配 Nurix Therapeutics 或代码 NRIX 的头条新闻，按最新排序。
- Needham Maintains Nurix Therapeutics(NRIX.US) With Buy Rating, Maintains Target Price $34
- RBC Capital Maintains Nurix Therapeutics(NRIX.US) With Buy Rating, Raises Target Price to $36 正面
- Jefferies Maintains Nurix Therapeutics(NRIX.US) With Buy Rating, Maintains Target Price $45
- Morgan Stanley Maintains Nurix Therapeutics(NRIX.US) With Buy Rating, Raises Target Price to $38 正面
- Morgan Stanley Maintains Nurix Therapeutics(NRIX.US) With Buy Rating, Maintains Target Price $38
- UBS Maintains Nurix Therapeutics(NRIX.US) With Buy Rating, Raises Target Price to $31 正面
- Wells Fargo Maintains Nurix Therapeutics(NRIX.US) With Hold Rating, Maintains Target Price $25
- Mizuho Securities Maintains Nurix Therapeutics(NRIX.US) With Buy Rating, Raises Target Price to $34 正面
- A Quick Look at Today's Ratings for Nurix Therapeutics(NRIX.US), With a Forecast Between $28 to $40
- BTIG Maintains Nurix Therapeutics(NRIX.US) With Buy Rating, Maintains Target Price $32
- Analysts Offer Insights on Healthcare Companies: Coya Therapeutics, Inc. (COYA), Nurix Therapeutics (NRIX) and Immunic (IMUX)
- A Quick Look at Today's Ratings for Nurix Therapeutics(NRIX.US), With a Forecast Between $25 to $45
- Oppenheimer Initiates Nurix Therapeutics(NRIX.US) With Buy Rating, Announces Target Price $28
- Stifel Maintains Nurix Therapeutics(NRIX.US) With Buy Rating, Maintains Target Price $34
- J.P. Morgan Maintains Nurix Therapeutics(NRIX.US) With Buy Rating
暂无评论——快来第一个聊聊 NRIX。
登录后参与讨论。